Novotech presented with Cell & Gene Excellence Award 2022 at 6th Cell & Gene...

Novotech, the leading Asia Pacific biotech specialist CRO, has been awarded the Cell & Gene Therapy Clinical Trials award at the 6th Cell &...
Avance Clinical

Avance Clinical Announces North American CRO Acquisition to Expand Later Phase Services for Biotechs

Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the acquisition of CRO partner company C3 Research Associates, enabling biotech...

Novotech at ESMO Congress 2022 – New Data Shows 100% Oncology Trials Growth in...

Meet the team at Booth #409 Novotech, the leading Asia Pacific biotech specialist CRO, will attend ESMO Congress 2022 with new data showing Asia...

APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report

Novotech, the leading Asia Pacific biotech specialist CRO has released new market data in a report now available titled "Evolution of Clinical Trials in...

Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding...

AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor Dr. Glenn Haifer and Ampersand Capital Partners, a global...
Avance Clinical

Avance Clinical Sponsors Biotech Company of the Year Awards at Informa Pharma Intelligence Awards...

Avance Clinical, the leading Australian CRO for international biotechs, is sponsoring two awards - Biotech Company of the Year Private and Public - at...

Legend Capital Portfolio: China-leading CRO Enterprise R&G Pharmastudies Listed on the ChiNext Market Successfully

On August 2, 2022, R&G Pharmastudies Co., Ltd. (SHE: 301333), a China-leading CRO enterprise invested by Legend Capital, was successfully listed on the ChiNext...

Virios Therapeutics: The ‘Virus Hypothesis’ That Stands to Change the Lives of 10M Americans

Company's September Phase 2b trial results could be transformative for fibromyalgia patients PCG Digital -- Life may change for the better for the 10 million...

Novotech’s Flexible Work Policy is Finalist in Best Workplace Flexibility Program “Excellence Award 2022”

Novotech, the leading Asia Pacific biotech specialist CRO with expanded services in the US, has been recognised for its innovative approach to workplace flexibility. Novotech...

TrialWire Technology Platform Rolls Out World First SMS/Text Patient Contact System Across all Studies...

TrialWire(TM) Technology Platform, the most secure and rapid digital patient recruitment Platform for trial rescue, today announced the rollout of the proprietary SMS/Text patient...

Therapeutic Goods Administration Grants Provisional Approval for Moderna’s COVID-19 Vaccine in Children Aged Six...

Announcement follows recent authorization of the Company's mRNA COVID-19 vaccine in Argentina, Canada, Israel, the US, and Taiwan for active immunization to prevent...

Novotech and Endpoints Present “Evolution of Cell & Gene Therapy in China: The Case...

Novotech, the leading Asia Pacific biotech specialist CRO with expanded services in the US, is pleased to present an Endpoints webinar on CAR-T therapy...

TrialWire Technology Platform Announces Success-based Patient Recruitment Plan

TrialWire(TM) Technology Platform, the fastest and most secure digital patient recruitment Platform for trial rescue powered by Salesforce Health Cloud, today announced the launch...

Novotech Client SK bioscience Achieves SKYCovione(TM) COVID-19 Vaccine Approval in Korea

Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, congratulates its client SK bioscience on the...

Novotech Receives “Best Biologics CRO Award 2022” at Korea Bioprocessing Excellence Awards 2022

Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was today awarded the Best Biologics CRO...

Novotech Receives CRO Leadership Award for Exceeding Customer Expectations

Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, was awarded a prestigious Clinical Leader and...

Novotech’s APAC and USA Leadership Teams at BIO 2022

Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, will have key executives from APAC and...

Novotech Sponsors Endpoints ASCO 2022 Expert Panel on Accelerating Oncology Clinical Trials in China

Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, is sponsoring the Endpoints ASCO22 "Accelerating clinical...

Novotech Sponsors Pre-ASCO China Summit Expert Panels on Early Phase Oncology Trials and Regulatory...

Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its services to the US, has sponsored expert panels at the Pre-ASCO...

Novotech Sponsors Pre-ASCO China Summit: Go/No Go Decisions Based on Early Phase Oncology Trials

Novotech, the leading Asia Pacific biotech specialist CRO which has recently expanded its CRO services to the US, is pleased to sponsor the Pre-ASCO...